Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Multicenter, Open-label, Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta

NCT00982124 is registered in ClinicalTrials.gov with Shriners Hospitals for Children as lead sponsor.

NCT NCT00982124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00982124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Multicenter, Open-label, Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta
Lead sponsor
Shriners Hospitals for Children
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2007
Completion date
April 30, 2016
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteogenesis imperfecta